TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence: selects Novotech

Multi-national Study to be Conducted by Novotech in Australia, New Zealand, and South Korea MOUNTAIN VIEW, California, and SYDNEY, Australia, May 16, 2011 /PRNewswire-iReach/ — TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, announced the start of a Phase 2 clinical trial of its lead product candidate THVD-201 for the treatment [...]

Novotech in new research collaboration: Biotechnology News

LEADING Australian contract clinical research company Novotech, Marine Biotechnology Australia and the University of Sydney are taking part in a new herpes research collaboration backed by the Academic Research Council (ARC). See full article

Australian Life Scientist

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed California-based biopharma company, OncoMed Pharmaceuticals, has announced it will run three Phase Ib clinical trials in Australia and New Zealand testing its humanised monoclonal antibody therapies for cancer. View online article For a licensed copy [CAL] of this article please email us at: [...]

CIO

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research. Novotech works with leading biotechnology and pharmaceutical companies to bring new healthcare products to [...]

iTnews

Novotech runs clinical trials on Oracle  A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. Novotech has announced that it will license about $500,000 of Oracle Siebel software to help manage clinical research trials at 400 hospitals and health [...]

Outsourcing Pharma

Podcast: Asia Pacific trial sector poised for continued growth, says Novotech The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.   Outsourcing Pharma Podcast For a licensed copy [CAL] of this article please [...]

Trials In Focus

Inside Stories – Wide brief for cancer candidate A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. The aim of all three trials is to determine the safety, efficacy, pharmacokinetics and maximum tolerated dose of OMR-21M18 when combined with [...]

Trials In Focus

Inside Stories – Asian trial growth creates hurdles Despite rapid growth in clinical trial activity across Asia, sponsors and CROs need to take care in managing unfamiliar environments says the CEO of Australian-based CRO, Novotech. Alek Safarian told the 46th annual meeting of the Drug Information Association (DIA) in Washington DC last week that regulatory [...]

CenterWatch

Novotech Becomes Medidata Solutions’ Partner Medidata Solutions, a global eClinical provider, announced that Australian contract research organization (CRO) Novotech has joined Medidata’s ASPire to Win channel partner program. As Australia’s largest full-service Australian CRO with extensive operations across Asia, Novotech can now offer sponsors a full range of services around the Medidata Rave electronic data [...]

Medidata Solutions Welcomes First Australian CRO to ASPire to Win Channel Partner Program

Medidata Solutions Welcomes First Australian CRO to ASPire to Win Channel Partner Program Sydney-based Novotech Adds Global Services for Medidata Rave Clinical Trial Technology NEW YORK, N.Y. – June 1, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Australian contract research organization (CRO) Novotech has [...]

Next Page »